Patent details

Basic Information

Publication number:

EP2940129

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP150016699

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

METHODS AND COMPOSITIONS FOR LIVE ATTENUATED VIRUSES

French Title of Invention:

PROCÉDÉS ET COMPOSITIONS POUR VIRUS VIVANTS ATTÉNUÉS

German Title of Invention:

VERFAHREN UND ZUSAMMENSETZUNGEN FÜR LEBEND ABGESCHWÄCHTE VIREN

SPC Number:

Dates

Filing date:

04/04/2008

Grant date:

06/05/2020

EP Publication Date:

04/11/2015

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

06/05/2020

EP B1 Publication Date:

06/05/2020

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

04/04/2021

Expiration date:

04/04/2028

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

29/04/2020

 

 

Name:

Takeda Vaccines, Inc.

Address:

75 Sidney Street, Cambridge, MA 02139, United States (US)

Inventor

1

Name:

Stinchcomb, Dan T.

Address:

United States (US)

2

Name:

Osorio, Jorge E.

Address:

United States (US)

3

Name:

Wiggan, O'Neil

Address:

United States (US)

Priority

Priority Number:

910579 P

Priority Date:

06/04/2007

Priority Country:

United States (US)

Classification

IPC classification:

A61K 39/12; C12N 7/02; C12N 7/04;

Publication

European Patent Bulletin

Issue number:

202019

Publication date:

06/05/2020

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages